2019
Association of rare non-coding SNVs in the lung-specific FOXF1 enhancer with a mitigation of the lethal ACDMPV phenotype
SZAFRANSKI, Przemyslaw, Qian LIU, Justyna A. KAROLAK, Xiaofei SONG, Nicole DE LEEUW et. al.Základní údaje
Originální název
Association of rare non-coding SNVs in the lung-specific FOXF1 enhancer with a mitigation of the lethal ACDMPV phenotype
Autoři
SZAFRANSKI, Przemyslaw (840 Spojené státy, garant), Qian LIU (840 Spojené státy), Justyna A. KAROLAK (840 Spojené státy), Xiaofei SONG (840 Spojené státy), Nicole DE LEEUW (528 Nizozemské království), Brigitte FAAS (528 Nizozemské království), Romana GERYCHOVÁ (203 Česká republika, domácí), Petr JANKŮ (203 Česká republika, domácí), Marta JEŽOVÁ (203 Česká republika, domácí), Iveta VALÁŠKOVÁ (203 Česká republika, domácí), Kathleen A. GIBBS (840 Spojené státy), Lea F. SURREY (840 Spojené státy), Virginie POISSON (124 Kanada), Denis BERUBE (124 Kanada), Luc L. OLIGNY (124 Kanada), Jacques L. MICHAUD (124 Kanada), Edwina POPEK (840 Spojené státy) a Pawel STANKIEWICZ (840 Spojené státy)
Vydání
Human Genetics, NEW YORK, SPRINGER, 2019, 0340-6717
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
10603 Genetics and heredity
Stát vydavatele
Spojené státy
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 5.743
Kód RIV
RIV/00216224:14110/19:00112517
Organizační jednotka
Lékařská fakulta
UT WoS
000493929500001
Klíčová slova anglicky
ALVEOLAR-CAPILLARY DYSPLASIA; MICE HETEROZYGOUS NULL; PULMONARY VEINS; GENE FOXF1; MISALIGNMENT; TRANSCRIPTION; VARIANTS; VESSELS; HAPLOINSUFFICIENCY; EXPRESSION
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 17. 1. 2020 14:22, Mgr. Tereza Miškechová
Anotace
V originále
Haploinsufficiency of FOXF1 causes alveolar capillary dysplasia with misalignment of pulmonary veins (ACDMPV), a lethal neonatal lung developmental disorder. We describe two similar heterozygous CNV deletions involving the FOXF1 enhancer and re-analyze FOXF1 missense mutation, all associated with an unexpectedly mitigated disease phenotype. In one case, the deletion of the maternal allele of the FOXF1 enhancer caused pulmonary hypertension and histopathologically diagnosed MPV without the typical ACD features. In the second case, the deletion of the paternal enhancer resulted in ACDMPV rather than the expected neonatal lethality. In both cases, FOXF1 expression in lung tissue was higher than usually seen or expected in patients with similar deletions, suggesting an increased activity of the remaining allele of the enhancer. Sequencing of these alleles revealed two rare SNVs, rs150502618-A and rs79301423-T, mapping to the partially overlapping binding sites for TFAP2s and CTCF in the core region of the enhancer. Moreover, in a family with three histopathologically-diagnosed ACDMPV siblings whose missense FOXF1 mutation was inherited from the healthy non-mosaic carrier mother, we have identified a rare SNV rs28571077-A within 2-kb of the above-mentioned non-coding SNVs in the FOXF1 enhancer in the mother, that was absent in the affected newborns and 13 unrelated ACDMPV patients with CNV deletions of this genomic region. Based on the low population frequencies of these three variants, their absence in ACDMPV patients, the results of reporter assay, RNAi and EMSA experiments, and in silico predictions, we propose that the described SNVs might have acted on FOXF1 enhancer as hypermorphs.